Skip to main content
[Preprint]. 2023 Jul 28:2023.07.27.550884. [Version 1] doi: 10.1101/2023.07.27.550884

Figure 2: Microglia and astrocytic coverage around compact, intermediate, and filamentous amyloid plaques between AD and AsymAD cases.

Figure 2:

A. Staining against the activated microglia marker IBA1 (red) and the activated astrocytic marker GFAP (purple) around the three previously classified thioflavin S amyloid plaque phenotypes B-C. Overall IBA1 (B) and GFAP (C) coverage quantification. Data is shown as mean ±SEM, unpaired Student’s t-test, n=14 cases, per condition (n.s.; 0.097 and 0.076, respectively) D-E IBA1 (D) and GFAP (E) coverage per plaque phenotype. Data is shown as ±SEM, 2-way ANOVA, following Šídák’s multiple comparisons test, n=14 cases, per condition.